self-assembled monolayers; SLD, scattering length density; SMW, silicon matched water; SSI, surgical site infections; SRS, standard reaction solution; TMPA, 3-(trimethoxysilyl)propyl acrylate; TSA, tryptone soya agar.
ABSTRACTHT61 is a quinoline-derived antimicrobial, which exhibits bactericidal potency against both multiplying and quiescent methicillin resistant and sensitive Staphylococcus aureus, and has been proposed as an adjunct for other antimicrobials in order to extend their usefulness in the face of increasing antimicrobial resistance. In this study we have examined HT61's effect on the permeability of Staphylococcus aureus membranes and whether this putative activity can be attributed to an interaction with lipid bilayers. Using membrane potential and ATP release assays, we have shown that HT61 disrupts the membrane enough to results in depolarisation of the membrane and release of intercellular constituents at concentrations above and below the minimum inhibitory concentration of the drug. Utilising both monolayer subphase injection and neutron reflectometry we have shown that increasing the anionic lipid content of the membrane leads to a more marked effect of the drug. In bilayers containing 25 mol% phosphatidylglycerol, neutron reflectometry data suggests that exposure to HT61 increases the level of solvent in the hydrophobic region of the membrane, which is indicative of gross structural damage. Increasing the proportion of PG elicits a concomitant level of membrane damage resulting in almost total destruction when 75 mol% phosphatidylglycerol is present.We therefore propose that HT61's primary action is directed towards the cytoplasmic membrane of Gram positive bacteria.The quinoline-derived cationic antimicrobial HT61 [1] was initially developed to improve the success of nasal decolonisation interventions aimed at decreasing the risk of post-operative surgical site infections (SSI) posed by carriage of methicillin resistant Staphylococcus aureus (MRSA) [2,3] . However, more recently it has been proposed as a resistance breaker to be used in conjunction with other more established antimicrobials [4] . Although the protein synthesis inhibitor mupirocin is currently widely used for anti-MRSA nasal decolonisation, it is not active against non-multiplying persister bacteria which constitute a reservoir for recolonisation [5] . In addition to this, an increased prevalence of mupirocin resistant MRSA [6] has led to the development of more effective alternatives, including the experimental antimicrobials LTX-109 [7] and XF-73 [8] in addition to HT61 [1] .The mode of action of HT61 has not hitherto been thoroughly investigated, however initial cell-based assays showed that HT61 is capable of depolarising the cytoplasmic membrane ofGram positives with further evidence from electron microscopy suggesting that HT61 causes lysis of either the membrane or cell wall [1,4] . The putative membrane-targeting of HT61 may provide some explanation for its potency against non-multiplying MRSA [9] , and suggests that...